Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 8, 2013University of Pittsburgh independent study of contemporary heart failure devices highlights industry-leading Boston Scientific battery longevity
An independent and first-of-its-kind study from the University of Pittsburgh Medical Center, published online this week in EP EuroPace, shows there are significant differences in battery longevity...
-
Sep 26, 2013REPRISE-II-Daten wurden im Rahmen des PCR London Valves Course zum "Best Abstract 2013" gekürt
Boston Scientific Corporation (NYSE: BSX) hat die positiven 6-Monats-Daten für die ersten 60 Probanden der klinischen Studie REPRISE II vorgelegt, die die Sicherheit und Effizienz...
-
Sep 25, 2013Boston Scientific comunica i risultati positivi a sei mesi dello studio clinico sulla valvola Lotus™I dati di REPRISE II premiati con il Miglior Abstract 2013 al PCR London Valves Course
La Boston Scientific Corporation (NYSE: BSX) ha comunicato i risultati positivi a sei mesi dei primi 60 pazienti arruolati nello studio clinico REPRISE II che valutava la sicurezza e la...
-
Sep 17, 2013
REPRISE II Data Honored as Best Abstract 2013 at PCR London Valves Course Boston Scientific Corporation (NYSE: BSX) reported favorable six-month results from the first 60 patients enrolled in the...
-
Sep 12, 2013
In a significant milestone toward obtaining additional key regulatory approvals for the SYNERGY™ Stent System, Boston Scientific Corporation (NYSE: BSX) has completed enrollment in the EVOLVE II...